« Previous
Next »
Titles
- A randomized trial testing the effect of narrative vignettes versus guideline summaries on provider response to a professional organization clinical policy for safe opioid prescribing1
- Antibiotics: FDA has encouraged development, but needs to clarify the role of draft guidance and develop qualified infectious disease product guidance : report to Congressional requesters1
- CT contrast media power injectors can rupture conventional IV sets1
- DSCSA standards for the interoperable exchange of information for tracing of certain human, finished, prescription drugs: guidance for industry1
- FDA should further integrate its review of cybersecurity into the premarket review process for medical devices1
- Hazardous spills: the safe handling of hazardous drugs1
- Managing patients with limited English proficiency1
- Medicare Advantage benefit design: what does it provide, what doesn't it provide, and should standards apply?1
- Multidrug-resistant organisms--strategies to reduce infection1
- No free lunch?: current challenges facing National School Lunch and School Breakfast Programs1
- SCHIP at the crossroads: California's options in responding to new federal funding conditions1
- Standards development and the use of standards in regulatory submissions reviewed in the Center for Biologics Evaluation and Research1
- Surgical fires: trends associated with prevention efforts1
- Use of International Standard ISO 10993-1, "Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process": guidance for industry and Food and Drug Administration staff1
- Veterans health care: additional actions could further improve policy management : report to Congressional requesters1